These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674 [TBL] [Abstract][Full Text] [Related]
26. [The value of tumor markers in digestive oncology]. Ychou M; Rougier P; Bidart JM; Bellet D; Tigaud JM; Bohuon C Ann Chir; 1989; 43(7):517-23. PubMed ID: 2694905 [TBL] [Abstract][Full Text] [Related]
27. Markers for hepatocellular carcinoma. Wu AH; Sell S Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067 [TBL] [Abstract][Full Text] [Related]
28. Tumour markers in pancreatic cancer. Haglund C; Kuusela P; Roberts PJ Ann Chir Gynaecol; 1989; 78(1):41-53. PubMed ID: 2667448 [TBL] [Abstract][Full Text] [Related]
29. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma. Safi F; Roscher R; Beger HG Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502 [TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma]. Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964 [TBL] [Abstract][Full Text] [Related]
31. [Tumor markers in internal medicine hepatology]. Vogel W; Judmaier G Wien Klin Wochenschr; 1989 Jul; 101(14):484-9. PubMed ID: 2549732 [TBL] [Abstract][Full Text] [Related]
34. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR. Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599 [TBL] [Abstract][Full Text] [Related]
35. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
36. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas. Enjoji M; Nakashima M; Yamaguchi K; Kotoh K; Nakamuta M J Gastroenterol Hepatol; 2005 Aug; 20(8):1143-8. PubMed ID: 16048560 [TBL] [Abstract][Full Text] [Related]